Pre- and Postpandemic Estimates of 2009 Pandemic Influenza A(H1N1) Seroprotection to Inform Surveillance-Based Incidence, by Age, During the 2013–2014 Epidemic in Canada-Reference-Cited by-同舟云学术

Pre- and Postpandemic Estimates of 2009 Pandemic Influenza A(H1N1) Seroprotection to Inform Surveillance-Based Incidence, by Age, During the 2013–2014 Epidemic in Canada

Published:2014-06-27 Issue:1 Volume:211 Page:109-114
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Skowronski Danuta M.,Chambers Catharine,Sabaiduc Suzana,Janjua Naveed Z.,Li Guiyun,Petric Martin,Krajden Mel,Purych Dale,Li Yan,De Serres Gaston

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/211/1/109/13805232/jiu366.pdf

Reference15 articles.

1. Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age

2. Public Health Agency of Canada. FluWatch: weekly reports 2013-2014 season. Ottawa: Public Health Agency of Canada; 2014. http://www.phac-aspc.gc.ca/fluwatch/index-eng.php. Accessed 14 July 2014.

3. Skowronski D Chambers C Sabaiduc S . Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada's sentinel surveillance network, January 2014. Euro Surveill 2014;19. pii:20690.

4. BC Centre for Disease Control. BC influenza surveillance bulletins: 2013-2014. Vancouver: BC Centre for Disease Control; 2014. http://www.bccdc.ca/dis-cond/DiseaseStatsReports/influSurveillanceReports.htm Accessed 11 April 2014.

5. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2014–2015 northern hemisphere influenza season. Geneva: WHO; 2014. http://www.who.int/influenza/vaccines/virus/recommendations/201402_recommendation.pdf?ua=1 Accessed 11 April 2014.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada;Canadian Medical Association Journal;2023-10-29

2. Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada;Canadian Medical Association Journal;2022-12-04

3. Serial cross-sectional estimation of vaccine and infection-induced SARS-CoV-2 sero-prevalence in children and adults, British Columbia, Canada: March 2020 to August 2022;2022-09-09

4. Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020;2020-07-15

5. Influenza Vaccination: Accelerating the Process for New Vaccine Development in Older Adults;Vaccines for Older Adults: Current Practices and Future Opportunities;2020